Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genomic H3K36me2 enrichment profile for Vehicle or dimethyl fumarate-treated mouse bone marrow-derived neutrophil

ABSTRACT: This study focuses on the epigenomics and transcriptomic changes driven by the GSK3B gene in colon cancer, offering valuable insights into tumor biology and its progression. Gaining a deeper understanding of these processes may contribute to developing more effective therapeutic strategies and enhance prognostic outcomes.

ORGANISM(S): Mus musculus

PROVIDER: GSE333948 | GEO | 2026/06/19

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcriptome change led by GSK3B knockout (KO) in colon cancer RKO cells

Project description:This study focuses on the epigenomics and transcriptomic changes driven by the GSK3B gene in colon cancer, offering valuable insights into tumor biology and its progression. Gaining a deeper understanding of these processes may contribute to developing more effective therapeutic strategies and enhance prognostic outcomes.

2026-06-19 | GSE333940 | GEO

The effect of Intestinal epithelial GSK3B loss on transcriptomic profiles in the AOM/DSS-induced colon cancer model

2026-06-19 | GSE333936 | GEO

The scRNA-Seq analysis for the effect of Intestinal epithelial GSK3B loss in the AOM/DSS-induced colon cancer model

2026-06-19 | GSE333935 | GEO

ATAC-seq analysis of RKO cells with combinatorial genetic perturbations of H1FX and GSK3B.

2026-06-19 | GSE333945 | GEO

The effect of Intestinal epithelial GSK3B loss on chromatin accessibility in the AOM/DSS-induced colon cancer model

2026-06-19 | GSE333943 | GEO

Impact of GSK3B on accessible chromatin regions in colon cancer RKO cells

2026-06-19 | GSE333941 | GEO

Impact of GSK3B on genome-wide H3K27ac in colon cancer RKO cells

2026-06-19 | GSE333942 | GEO

Genomic H3K36me2 enrichment profile for Vehicle or dimethyl fumarate-treated mouse bone marrow-derived neutrophil

Project description:Genomic H3K36me2 enrichment profile for Vehicle or dimethyl fumarate-treated mouse bone marrow-derived neutrophil

| PRJNA1473268 | ENA

Diet modulates the protective effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCA2

Project description:Monomethyl fumarate (MMF) and its prodrug dimethyl fumarate (DMF) are currently the most widely used agents for the treatment of multiple sclerosis (MS). However, not all patients benefit from DMF. We hypothesized that the variable response of patients may be due to their diet. In support of this hypothesis, mice subjected to experimental autoimmune encephalomyelitis (EAE), a model of MS, did not benefit from DMF treatment when fed a lauric acid-rich (LA) diet, in contrast to normal chow (NC) or, more so, a high-fiber (HFb) diet. DMF lacked efficacy in the LA diet fed group despite similar resorption and preserved effects on plasma lipids. When mice were fed the permissive HFb diet, the protective effect of DMF treatment depended on hydroxycarboxylic receptor 2 (HCA2) which is highly expressed in neutrophil granulocytes. Indeed, deletion of Hca2 in neutrophils abrogated DMF protective effects. Diet had a profound effect on the transcriptional profile of neutrophils and modulated their response to MMF. In summary, DMF required HCA2 on neutrophils as well as permissive dietary effects for its therapeutic action. Translating the dietary intervention into the clinic may improve MS therapy.

2025-05-25 | GSE263752 | GEO